Prof. Dr. Yuri Gleba, CEO of Nomad Bioscience gave the interview to Transkript: Wirtschaft, Technologie, Leben magazine

Wirtschaft, Technologie, Leben magazine

Related articles

NOMAD Bioscience Extends Agreements with Plant Biomass Producers in Extremadura Spain

NOMAD Bioscience Extends Agreements with Plant Biomass Producers in Extremadura Spain Munich, June, 2023 – NOMAD BIOSCIENCE GmbH, Munich, Germany…

Nomad Bioscience and Fraunhofer Institute of Cell Therapy and Immunology Extend their Research and Development Agreement

Nomad Bioscience and Fraunhofer Institute of Cell Therapy and Immunology Extend their Research and Development Agreement Nomad Bioscience GmbH, Munich,…

NOMAD Bioscience receives patents in Japan and Australia for its antibacterials Salmocins

NOMAD Bioscience receives patents in Japan and Australia for its antibacterials Salmocins Munich, October 2022 – NOMAD Bioscience GmbH has…

NOMADS UAB, Lithuania Published a Milestone Research Paper Describing its Chimeric Bacteriocins for Control of Multidrug-Resistant Pseudomonas

NOMADS UAB, Lithuania Published a Milestone Research Paper Describing its Chimeric Bacteriocins for Control of Multidrug-Resistant Pseudomonas NOMADS UAB, Lithuania,…